Deutsche Bank Maintains Buy Rating on LabCorp of America

According to Deutsche Bank, LabCorp of America LH Buy rating is maintained. Deutsche Bank said that it believes buy-side expectations for LH are relatively low, but it's heard concern from many investors that LH might use Q3's CC to signal lower near/medium-term growth in light of the sluggish economy. “While LH doesn't provide forwardyear guidance until Q4, we believe the Q3 print and management's nearterm outlook will be particularly important for the shares, which have pulledback 13% in the past 3 months vs. -6% for the S&P 500.” LabCorp of America closed yesterday at $82.58.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorAnalyst RatingsDeutsche BankHealth CareHealth Care Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!